Clinical Research Directory
Browse clinical research sites, groups, and studies.
The EYERISING Study
Sponsor: University of Wisconsin, Madison
Summary
The purpose of this clinical trial is to see if and how well Repeated Low-Level Red Light (RLRL) therapy works to control myopia over 12 months. The main question it aims to answer is: * Can RLRL therapy help slow down the worsening of myopia? Participants will use a red-light therapy investigational device at home, 5 days a week for 12 months.
Official title: Repeated Low-level Red Light for Myopia Progression Study: An International, Multicenter, Multiethnic, Randomized Controlled Trial, IPOSC Study
Key Details
Gender
All
Age Range
6 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
333
Start Date
2026-10
Completion Date
2029-03
Last Updated
2026-11-02
Healthy Volunteers
No
Conditions
Interventions
Repeated Low-Level Red Light (RLRL) therapy
RLRL device emits low-level red-light with a wavelength of 650 ± 10 nm. The device provides light at a power of 2.00 ± 0.50 mW.
Placebo Device
Placebo device will match the RLRL in appearance but will not emit light.
Locations (2)
University of Wisconsin - Madison
Madison, Wisconsin, United States
Tilganga Institute of Ophthalmology
Kathmandu, Bagmati Province, Nepal